Merck & Co
Merck & Co

Financials • Merck & Co

MRK

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Complete and updated financials table with all primary indicators: Net Income, Revenue, EBITDA, Margin, ROE, Dividends

Year
12/2016
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
12/2017
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
12/2018
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
12/2019
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
12/2020
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
12/2021
48,704
15,752
01,345
27%
5.1
38,184
34%
25,006
1.6
13,630
-4,448
2,593
9,182
-840
-6,610
51%
3.4%
12/2022
59,283
21,854
01,345
24%
5.7
45,991
32%
17,499
0.8
18,554
-4,388
-9,119
14,166
0
-7,012
48%
2.5%
12/2023
60,115
6,227
012
0.6%
0.14
37,581
1%
27,962
4.5
12,361
-3,863
-4,810
8,498
-1,346
-7,445
2,000%
2.7%
12/2024
64,168
24,411
01,345
27%
6.7
46,313
37%
23,422
0.96
20,707
-3,372
-7,032
17,335
-1,306
-7,840
46%
3.1%
12/2025
65,011
27,056
01,345
28%
7.3
52,606
35%
34,774
1.3
15,652
-4,112
-1,922
11,540
-5,084
-8,176
45%
3.1%

To see all financials—including updated, you must be Premium.